🔎 Trials Near Me

Akèy › Kansè nan tete › Kalifòni › Westminster

Etid klinik pou Kansè nan tete nan Westminster, CA

7 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Westminster (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Ap rekriteFaz 2
  • Cancer & Blood Research Center, Los Alamitos · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07102381

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Ap rekrite
  • Cancer and Blood Research Center, Los Alamitos · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07214532

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Ap rekriteFaz 3
  • Clinical Trial Site, Los Alamitos · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07085767

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Ap rekriteFaz 3
  • Cancer and Blood Specialty Clinic (CBSC), Los Alamitos · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07173751

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Ap rekriteFaz 3
  • Cancer and Blood Research Center, LLC, Los Alamitos · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06492616

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Ap rekriteFaz 2
  • Cancer Blood and Specialty Clinic, Los Alamitos · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Nov 10, 2025 · NCT04553770

Etid Kansè nan tete nan lòt vil

Lòt etid nan Westminster

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.